Karolinska Development AB (publ)
OTC: KDEVF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Viktor Drvota
- Employees
- 8
- Headquarters
- Solna, Sweden
- IPO year
- 2019
- Market cap
- $68.9M
- Website
- https://www.karolinskadevelopment.com
Loading KDEVF…
Loading profile data…Frequently asked questions about KDEVF
What does Karolinska Development AB (publ) (KDEVF) do?
Karolinska Development AB (publ) operates as a venture capital firm, primarily focused on providing funding to nascent companies across seed, early, and growth stages. Its investment strategy targets a wide array of life science domains, including pharmaceutical and genetic research and development, medical advancements, healthcare technology, i...
Where does KDEVF trade?
Karolinska Development AB (publ) (KDEVF) trades on the Other OTC.
What sector is KDEVF in?
Karolinska Development AB (publ) (KDEVF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Karolinska Development AB (publ)?
Viktor Drvota is the chief executive officer of Karolinska Development AB (publ) (KDEVF).
Where is Karolinska Development AB (publ) headquartered?
Karolinska Development AB (publ) is headquartered in Sweden.
Does KDEVF pay a dividend?
Karolinska Development AB (publ) (KDEVF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KDEVF go public?
Karolinska Development AB (publ) (KDEVF) completed its initial public offering in 2019.